Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

11-18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
24-05-06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Market Cap	519K 448K 412K 387K 728K 48.98M 734K 4.88M 1.9M 24.04M 1.95M 1.91M 83.16M	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	22.05M 19.02M 17.49M 16.46M 30.93M 2.08B 31.19M 207M 80.68M 1.02B 82.75M 80.98M 3.53B	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

11-18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
24-05-06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-01	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-31	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
23-11-14	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-10-04	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
23-10-01	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
23-09-29	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
23-08-15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-08-01	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
23-07-09	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
23-07-09	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
23-06-15	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

11-18	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
24-05-16	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
24-05-16	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
23-10-05	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
23-10-02	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-0.94%	-2.14%	+40.54%	+148.38%	992B
JOHNSON & JOHNSON	-0.42%	-1.80%	+53.69%	+42.60%	564B
ABBVIE INC.	-0.56%	-1.65%	+19.27%	+59.57%	391B
ROCHE HOLDING AG	-1.18%	+0.68%	+24.66%	+16.53%	330B
ASTRAZENECA PLC	+1.42%	+0.06%	+26.36%	+14.29%	280B
NOVARTIS AG	+1.09%	+1.65%	+26.61%	+33.32%	279B
NOVO NORDISK A/S	+1.87%	+0.87%	-41.49%	-48.26%	196B
AMGEN INC.	-1.78%	+1.16%	+17.79%	+48.77%	184B
GILEAD SCIENCES, INC.	-1.40%	+3.27%	+16.16%	+59.08%	156B
Average	-0.21%	+0.41%	+20.40%	+41.59%	374.58B
Weighted average by Cap.	-0.37%	-0.49%	+29.25%	+65.83%

Exactus Inc Stock OTC Bulletin Board

Stocks

US30066P1021

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

	2022	2023
Net sales	1.63M 1.4M 1.29M 1.21M 2.28M 154M 2.3M 15.29M 5.95M 75.36M 6.11M 5.98M 261M	2.38M 2.06M 1.89M 1.78M 3.35M 225M 3.37M 22.42M 8.73M 110M 8.95M 8.76M 382M
Net income	-9.14M -7.89M -7.25M -6.83M -12.83M -863M -12.93M -85.93M -33.46M -423M -34.31M -33.58M -1.46B	-8.02M -6.91M -6.36M -5.98M -11.24M -756M -11.34M -75.34M -29.33M -371M -30.08M -29.44M -1.28B
Net Debt	17.85M 15.4M 14.16M 13.33M 25.05M 1.68B 25.26M 168M 65.33M 827M 67.01M 65.58M 2.86B	21.53M 18.57M 17.08M 16.07M 30.2M 2.03B 30.46M 202M 78.78M 997M 80.8M 79.08M 3.45B